Who Owns Mineralys Therapeutics Stock?
NASDAQ: MLYSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 117.54%
- Institutions (% of float)
- 118.37%
- Held by insiders
- 0.70%
- Institutional holders
- 322
- Institutions 99.3%
- Insiders 0.7%
- Public and other 0.0%
Who owns Mineralys Therapeutics stock?
Institutional investors own about 117.5% of Mineralys Therapeutics's shares, spread across 322 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.70% of MLYS.
The largest institutional holders are Catalys Pacific, LLC (8.94%), RA Capital Management, L.P. (8.70%) and Blackrock Inc. (6.66%). Together, the top 10 institutions control 53.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MLYS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MLYS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Catalys Pacific, LLC | 7.90M | 8.94% | 0.0% |
| RA Capital Management, L.P. | 7.69M | 8.70% | 0.0% |
| Blackrock Inc. | 5.89M | 6.66% | +31.4% |
| Samsara BioCapital, LLC | 5.87M | 6.64% | 0.0% |
| FMR, LLC | 4.51M | 5.10% | -7.2% |
| State Street Corporation | 4.14M | 4.68% | +41.1% |
| Deerfield Management Company, L.P | 3.96M | 4.48% | +100.0% |
| Vanguard Capital Management LLC | 2.76M | 3.12% | +12.3% |
| Laurion Capital Management, LP | 2.51M | 2.83% | +12.3% |
| Price (T.Rowe) Associates Inc | 2.26M | 2.56% | +68.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MLYS
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.97M | 3.36% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.97M | 2.23% |
| SmallCap World Fund Inc | 1.65M | 1.87% |
| iShares Trust-iShares Russell 2000 ETF | 1.47M | 1.67% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.18M | 1.33% |
| T. Rowe Price New Horizons Fund, Inc. | 828.60K | 0.94% |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 792.38K | 0.90% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 728.43K | 0.82% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 630.00K | 0.71% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 627.89K | 0.71% |
Frequently asked questions
Who is the largest shareholder of Mineralys Therapeutics?
Catalys Pacific, LLC is the largest institutional shareholder of MLYS, owning 8.94% of shares outstanding (7.90M shares) as of its latest 13F filing.
What percentage of Mineralys Therapeutics is owned by institutions?
Institutions own about 117.5% of MLYS shares and 118.4% of the public float.
How much of Mineralys Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.70% of MLYS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.